Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Lund den 23 september, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) meddelar att nya data från fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom kommer att presenteras i Nice,...
-
Lund Sweden, September 23, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that new data from exploratory analysis of the Phase 2 LEGATO-HD study of laquinimod in Huntington’s disease...
-
Väsentliga händelser under kvartal 2 Extra bolagsstämma den 4 april 2019, beslöt i enlighet med styrelsens förslag, om godkännande av överlåtelse av bolagets fastighet, till Estea...
-
Significant events during the second quarter In accordance with the Board’s proposal, the Extraordinary General Meeting on April 4, 2019, resolved to approve the sale of the company’s...
-
PRESSMEDDELANDE Active Biotechs årsstämma hölls den 23 maj 2019. I enlighet med styrelsens förslag beslöts att ingen utdelning skulle lämnas. Styrelsens ledamöter och verkställande direktören...
-
PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 23, 2019. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The...
-
PRESSMEDDELANDE Lund den 3 maj, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) meddelar att data från fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom har blivit utvalt att presenteras...
-
PRESS RELEASE Lund Sweden, May 3, 2019 - Active Biotech (NASDAQ STOCKHOLM: ACTI) announces that data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease has been selected to be...
-
Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are appointed new members of the Board of...
-
PRESS RELEASE Lund 2 May, 2019 - Active Biotech (NASDAQ, STOCKHOLM:ACTI) announce that the Election Committee of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are...